PLX (STOCKS)
Protalix BioTherapeutics, Inc. Common Stock
$2.300000
+0.000000 (+0.00%)
Prev close: $2.300000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Dror Bashan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $186.12M
- Employees
- 213
- P/E (TTM)
- -27.46
- P/B (TTM)
- 3.87
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $52.74M |
| Benefits Costs and Expenses | $58.35M |
| Cost Of Revenue | $26.99M |
| Costs And Expenses | $58.35M |
| Gross Profit | $25.75M |
| Nonoperating Income/Loss | -$108.00K |
| Operating Expenses | $31.25M |
| Selling, General, and Administrative Expenses | $11.68M |
| Research and Development | $19.57M |
| Operating Income/Loss | -$5.50M |
| Income/Loss From Continuing Operations After Tax | -$6.60M |
| Income/Loss From Continuing Operations Before Tax | -$5.61M |
| Income Tax Expense/Benefit | $996.00K |
| Income Tax Expense/Benefit, Current | $656.00K |
| Income Tax Expense/Benefit, Deferred | $340.00K |
| Net Income/Loss | -$6.60M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$6.60M |
| Net Income/Loss Available To Common Stockholders, Basic | -$6.60M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.08 |
| Diluted Earnings Per Share | -$0.08 |
| Basic Average Shares | 78,546,234 |
| Diluted Average Shares | 78,546,234 |
| Assets | $82.35M |
| Current Assets | $66.67M |
| Inventory | $25.73M |
| Prepaid Expenses | $394.00K |
| Other Current Assets | $40.55M |
| Noncurrent Assets | $15.67M |
| Fixed Assets | $4.88M |
| Other Non-current Assets | $10.79M |
| Liabilities | $34.12M |
| Current Liabilities | $26.52M |
| Wages | $1.63M |
| Other Current Liabilities | $24.89M |
| Noncurrent Liabilities | $7.60M |
| Equity | $48.23M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $48.23M |
| Liabilities And Equity | $82.35M |
| Net Cash Flow From Operating Activities | -$11.99M |
| Net Cash Flow From Operating Activities, Continuing | -$11.99M |
| Net Cash Flow From Investing Activities | -$2.37M |
| Net Cash Flow From Investing Activities, Continuing | -$2.37M |
| Net Cash Flow From Financing Activities | $9.33M |
| Net Cash Flow From Financing Activities, Continuing | $9.33M |
| Net Cash Flow | -$5.03M |
| Net Cash Flow, Continuing | -$5.03M |
| Comprehensive Income/Loss | -$6.60M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$6.60M |
| Other Comprehensive Income/Loss | $0.00 |